附录3 英文目录示例

合集下载

58885-1-S-000-1610-0001_50_0010-1-Chinese-中英对照-第3版本-Final

Distribution:YPMTpage 1 of 28CONTRACTOR JOB NO. 承包商工号0-2700-20CONTRACTOR DOC NO. 承包商文件号S-000-1610-0001CNOOC AND SHELLPETROCHEMICALS COMPANY LTD CNOOC 和壳牌石油化工有限责任公司CSPC NANHAI PETROCHEMICALS PROJECT“LOP PROCESS UNIT” CSPC 南海石油化工项目 “LOP 工艺单元”LOCATION: HUIZHOU, PRC地点：中国，惠州CONSTRUCTION EXECUTION PLAN 施工实施方案PROJECT SPECIFICATION:项目规范 CS-8710-1000-0001Project Management Contractor (PMC)项目管理承包商Engineering, Procurement & Construction (EPC) Contractor设计、采购和施工承包商Document Security 文件保密9 : Level 1 : : Level 2 9 : Level 3 9 : Level 4 9 : Level 5 等级 1 等级 2 等级 3 等级 4 等级 5Document Issue Purpose 文件目的9 : For Approval 用于批准9 : For Review用于审核9 : For Information 供参考:: For Construction用于施工9 : Internal Use供内部使用50 4-SEP-0303CONTENTS目录1. INTRODUCTION 介绍2. CONSTRUCTION EXECUTION POLICY 施工实施政策3. DOCUMENT STRUCTURE OF CONSTRUCTION EXECUTIONPLAN 施工实施方案的文件结构4. HEALTH, SAFETY AND ENVIRONMENTAL (HSE) 健康，安全和环境（HSE）5. QUALITY ASSURANCE/ QUALITY CONTROL (QA/QC) 质量保证／质量控制（QA/QC）6. FIELD ORGANIZATION 现场组织7. LABOUR SOURCE AND POSTURE 劳动力来源和现状8. SUBCONTRACTING 分包9. FIELD CONTROL 现场控制10. WAREHOUSE AND MATERIAL HANDLING 仓库和材料搬运11 SCHEDULE OF WORK AND PATH OF CONSTRUCTION 工程进度和施工路线12 CONSTRUCTION EQUIPMENT AND SOURCE 施工设备和资源13 HANDOVER AND FINAL DOCUMENTATION 移交和交工文件14. TEMPORARY FACILITIES 临时设施15. INTERFACE COORDINATION WITH PMC/CONMANY ANDOTHERS 同PMC／公司和其他方的界面配合List-1 清单－1Related Procedure List for HSE 健康、安全和环境相关程序清单“CSO Organization Chart”“CSO组织架构图”Attachment – 1附件－1Temporary Facility Plan, General Layout 临时设施方案，总体布置Attachment – 2附件－21/4 Around Site 现场周围2/4 Offsite Laydown (F1 Area) 现场外堆场（F1区域）3/4 Onsite Laydown Yard 现场内堆场4/4 Labor Camp 工棚Attachment-3附Manpower Mobilization Plan 1/2 & 2/2 (Preliminary Inf.) 人员进场方案件－31/2 和2/2 （初步信息）Attachment-4 附件－4Area Layout CSPC AreaCSPC区域规划Plot Plan of LOP Unit LOP装置平面图Attachment-5附件－5Weather Impact 天气影响1. INTRODUCTION 介绍The purpose of this plan is to provide an overview of the strategy the Contractor will implement to successfully execute the construction phase of the CSPC Nanhai LOP Project. 本方案旨在提供一个承包商施工策略的总体概述，承包商将实施此策略以便成功地完成CSPC南海LOP项目的施工。

英语目录与提要范文

英语目录与提要范文In the realm of academic writing, the art of crafting a compelling table of contents and abstract is crucial. It sets the stage for the reader, providing a roadmap to the wealth of information that lies ahead.The table of contents should be a concise, hierarchical list that mirrors the structure of the document. It guides the reader through the chapters and sections, offering a glimpse of the journey they are about to embark upon.An effective abstract, on the other hand, is a brief summary that encapsulates the essence of the work. It should be engaging, highlighting the main points and findings, without revealing too much detail.For younger students, the table of contents might include simpler sections such as "Introduction," "Main Body," and "Conclusion." The abstract should be a single, well-crafted sentence that piques interest.As students advance, the complexity of the table of contents and abstract increases. Sections may be broken down further, and the abstract should provide a more detailed overview, yet still remain succinct.In a research paper, the table of contents might list specific chapters such as "Literature Review," "Methodology,""Results," and "Discussion." The abstract should succinctly introduce the research question, methods, key findings, and implications.For a novel or a creative piece, the table of contents could list chapters with intriguing titles that hint at the story's twists and turns. The abstract, or synopsis, should capture the reader's imagination, offering a taste of the narrative without giving away too much.In all cases, clarity and coherence are paramount. The table of contents and abstract must work in tandem, inviting the reader to delve deeper into the text, promising a rewarding exploration of ideas and insights.。

附录.外文翻译 doc

附录：英语文献及其英文The development of high-speed milling grinding machine industry The high speed in China whets to pare start not calculate too late, have already started developing high-speed grinding machine at the beginning of 70's in last century, obtain some piecemeal of achievement.The grinding machine profession convened whole country high speed to whet to pare a meeting in 1974, the meeting decided in the whole country to gradually expand high-speed grinding machine to combine to produce factory to associate design high-speed grinding machine from the grinding machine.In 1976, the grinding machine profession relevant factory house is in the tool machine factory concentration of Hangzhou carry on unite design, design a quite a few style product, among them M7132 high speed even whet appointed from original Chuang in the stone house three tool machine factory production, the line speed of the tool machine is also a 60 m/s.In 1978, original Chuang in the stone house third tool machine factory press consociation design diagram paper gave birth to 2 set high speed even whet, exhibit on the tool machine exposition of Wuhan at the same year and get a good character, but unfortunately can not carry on sale. Henceforth, the national national-economy gets into to adjust a period, the tool machine profession is subjected to impact, this 2 set the high-speed grinding machine always don't carry on sale and cause development and expansion of high-speed grinding machine suffer a defeat. In order to there being no the power of marketing demands, the high speed is even to whet at more than 10 years, stops a step not before. The high-speed even grinding development can not get into until 90's lately of the development expect.In 1992, Guizhou Zunyi Changzheng Eighth Electrical Appliance Factory for processing a high initial permeability perm alloy (IJ50) material, this material using conventional horizontal line speed of 35m/s milling, precision and surface roughness is not up to the technical requirements, but the use of high-speed grinding work piececan meet the requirements of. Under these circumstances, the unit asks Hang machine to provide one the set the high-speed grinding machine. Hence, refitted one set high speed for the unit on the MM7132 nicety even grinding foundation even whet, the emery wheel line speed attains a 60 m/s is above, use a circumstance better, acquired better economic efficiency.In 2005, the production of high-speed grinding machine gradually turns to from the special airplane product refitted a regular product, already set is the MMS7132.But allows multiuser usually for the sake of economical the equipments purchase expenses and rather purchase common tool machine again carry on refitting.Once designing around 2002 is well worth mentioning and experimented successful HZ-74/1 and MKS7130 two sets Be extremely high to is soon even to whet, these two set tool machines are Hang machines is developed with the property for cooperating with University of Hunan of, the line speed of the tallest emery wheel the former is 120 m/s, the latter more high as 314 m/s. The tool machine does in the university of Hunan extremely high soon whet to pare of experiment, technical personnel at extremely high soon even whet up to 45# materials, such as steels, stainless steel, tool steel, bearings steel and porcelain and ceramics etc. carried on to whet to pare experiment, especially professedly oxidize high PSZ and nitrogen to turn fire and oxidize materials like aluminum ,etc to carry on to the difficult hard frailty to efficiently and profoundly whet to pare, all come to a to a little bit ideally whet to pare effect. The tool machine is whetted to pare porcelain and ceramics material to also obtain better effect with the CBN emery wheel.Can say, this is China at extremely high soon whet to pare realm to obtain of had better become to accumulate, explain that we are in this realm is also have Be of. But generally speaking, manufacture and application of domestic high speed grinder is still modest state, application of high speed grinding machine has only a few other industries in electronics, has not been large-scale application. At high speed and extremely high soon whet to pare to study realm, China's University of Hunan efficiently whetted to pare a graduate school to make to beneficially try and obtained some achievements.China's high-speed flat grinding gap with the international advanced level:First, the normal regulations is even speed and the work set back and forth speed and foreign level whetting emery wheel line to compare a bigger margin. Line speed all generally in the 35 m/s is following; the emery wheel adopts more commonness of just jade emery wheel, carborundum emery wheel, the application of CBN, diamond emery wheel less. The abroad is even to whet emery wheel speed of 45 m/ s is above pretty much universal; even 60 m/s line speed also become the normal regulations speed of tool machine. It two, the yield of the high-speed grinding machine is few, the application isn't universal, so far, the grinding machine profession only has MMS7132 AN a kind of model number and specification, the tallest line speed 60 m/s. Tool machine is at MM7132 A nicety even whet foundation up change the system, enlargement whet a power of electrical engineering, adoption become to repeatedly equip exaltation to turn soon. Thickened an emery wheel protection cover hull, and raised the back and forth speed (35 m/min) of work set, enlarged to cool off liquid discharge. The emery wheel chooses high-speed emery wheel. Because customer less, tool machine batch quantity not big, many in the last years are just a little amount to produce, have in the whole product yield compare few. At extremely high soon whet to pare realm, although have already beneficially made to try, always say come, study aspect devotion shortage in the foundation, at high speed with extremely high soon whet to pare realm to lack thorough research, haven't established independence development study the plan of high-speed grinding machine. Didn't also provide for the customers so far extremely high soon and efficiently and profoundly take shape a grinding machine product, certainly this grinding machine products lacking a powerful market to prop up is also reason. Whet to anticipate to wait forerunner to whet to anticipate application and pare to experiment to the whetting of super hard nonmetal material to CBN etc. research also few, can not prop up for customer providing a powerful technique. In the aspects of producing to learn to grind severity become disjointed; have of just for fighting for item just. The match produced to learn to grind isn't enough, each attend to each benefits and interest, and cause the industry of achievement turn to lead lowly.Development high speed even whets some suggestions:(1)Sell difference to turn strategy in the product under, raise the emery wheel line of the normal regulations grinding machine product of having the representative speed appropriately, widespread raise the line speed to a 45 m/s, whet to pare an efficiency by exaltation. In other words, be develop some quasi- high-speed grinding machines, use some CBN efficiently whet to anticipate emery wheel on these tool machines. Certainly, the price of tool machine should also rise appropriately. These tool machines can expand in the particular profession. The method passing to raise emery wheel to turn soon attains the purpose of raising the production efficiency, this affirmation will be popular among the customer. Whet the technique progress for anticipating along with the local high-speed emery wheel in fact, the application of high-speed emery wheel can get gradually extension, completely can widespread raise the emery wheel line of normal regulations grinding machine speed and certainly need to pass the implementation of profession standard to take into to expand.(2)At"25" periods, particularly is the production that efficiently and profoundly takes shape grinding machine to have arrangement and programming to the high-speed grinding machine, make sure some tool machines with better inborn condition is radical type tool machine, develop high-speed grinding machine.(3)The customers who cultivate high-speed grinding machine are needing to be carried out most high-efficiency whet the professions like molding tool, etc paring to look for a customer, actively expand high speed to whet to pare a craft. The advantage that gradually makes the customer experience personally adoption high speed to whet to pare to bring them will aware of self ground to purchase high-speed grinding machine while purchasing tool machine equipments.(4)Carrying on is thorough of the high speed whet to pare a research, at extremely high soon whet to pare realm should also get involved in good time. Can foresee, who at extremely high soon whet to pare realm to obtain a research of achievement, who the ability be efficiently and profoundly whetting the development of paring the tool machine to obtain active power. The foundation technique research is still weak link and strengthens the quest to the lately technical research, new craft tohave very important meaning currently. Experimenting a work should bring into regular management, have plan and have budget and have a target, ensure an of every year achievement.(5)Develop producing of depth to learn to grind a technique cooperation, build up a suitable cooperation colleague and start a business in the domestic cluster, pass various outlet at nation, province, the city layer class row item, high speed with extremely high soon whet to pare item to be included in a plan, fight for the public finance that acquires government of support.(6)Wait various body of carrying through an exposition, whet to pare tool machine to carry on extensive publicity expansion to the high speed, consciously cultivate typical model customers.(7)To national tool machine the standard committee suggest, high speed and extremely high soon the standard establishment of the grinding machine list as to standardize a work contents. At the same time, further research should be carried out, such as ceramics industry needs and super high speed grinder and so on, in order to lead the domestic market.国内外磨床行业高速平磨发展概况中国的高速磨削起步不算太晚，上世纪70年代初已开始研制高速磨床，取得了一些零星的成果。

2019-合同通用条款范本目录(英文)word版本 (5页)

6. 保密义务
6.1 保密义务的范围
6.2 保密义务不适用的情形
6.3 保密制度
6.4 保密资料的归还
7. 违约
7.1 违约救济措施
7.2 责任限制
8. 不可抗力
8.1 不可抗力的定义
8.2 不可抗力的后果
9. 争议的解决
9.1 友好协商
9.2 仲裁
9.3 持续的权利和义务
9.4 裁决的执行
9.5 申请制止侵权、违约行为的权利
这个世界，唯文字可与生命相媲美。文字，活色生香，生命，踏过茉莉一样的芳香，遇见一份柔情，辗转一念执着；文字，如梦似幻，生命，跨过童话一般的世界，美妙一份梦幻，陶醉一份温馨；文字，五味人生，生命，尝过酸甜苦辣，遥看一席芳华，落满轻舞飞扬的缤纷枝叶，在风景如画的年华，筑起一份坚强与洒脱，如痴如醉，笑看人生。
5. Termination
5.1 Termination
5.2 Continuing Obligations
6. Confidentiality
6.1 Scope of Confidentiality
6.2 Exceptions
6.3 Confidentiality Rules and Regulations
11.4 Amendment
11.5 No Publicity
11.6 No Solicitation
11.7 Notices
11.8 Waiver
11.9 Assignability
11.10 Severability
11.11 Entire Agreement
11.12 Schedules and Annexes
8.2 Consequences of Force Majeure

英文产品目录

Name of Commodity Key wordsSolid Oak Dinning Chair Dinning Chair, Solid Oak Chair,Chair, Wooden ChairFashional PU DiningChair with ChromedLegs dining chair , chair ,PU chair ,leather chairHotel Chair wood chair , dining chair ,office chairDining Chair Dining Room Chairs ,Restaurant Used Dining Chairs ,Modern Dining ChairsAluminum StackingHotel BanquetRestaurant FurnitureDinning Chairs, ChairEames DSR Chair Eames DSR chair, Eames Chair, Dining Chair, dining room chair, chair, modern furnitureDining Chair dining chair, chair, restaurant chair, KFC chairChippendalechair(奇彭代尔式椅）diningchair, chippendale chairModern Home FurnitureStylish Dining Chair dining chair, stylish dining chair, home furniture dining chair, modern dining chairUpholstered Antique Fabric Dining Chair fabric dining chair, poker chair, oak leg chair, living room chairDining Chair dining chair, dining set, dining room furniture, home furnitureComfortable Dining Chair Related Keywords:dining chair, chair, comfortable dining chair，dining roomFashion Metal Dinning Chairs Home Steel Furnitures, Dinning Metal Chairs,Metal FurnitureDining Arm Chair Dining arm chair, Chair, Diningroom furniture, Arm chairDescription Delivery & Packing Simple Design.Legs: Solid Wood(实木）【Oak（橡木）,Pine（松木）or Customized（可定制）】Top material: PU,Eco Leather（环保皮）,Fabric（布） Color:Matt Lacquer（暗淡亮漆） or walnut oil（胡桃漆） or Customized(可定制）Size:43x49x108cm Packing : 2pcs per cartonDelivery Lead Time : 30days in normalMinimum Order : 500pcsSupply Ability : 50000pcs per monthMaterial: soft PU（软PU革） /steel with chromed（烙钢）Size: 440x480x960mmColor Available :black /white /beigeNet Weight（净重）(kgs): 7CBM （体积）(m3): 0.28Quality Guarantee（质量保障）: 3 years Packing : 4pcs/ctnPackaging Size(CM) : 46 x 50 x 98 Package Weight : 29.5 ( Kilograms )Delivery Lead Time : 15-30days Minimum Order : 100 pcsSupply Ability : 20000 pcs/monthFabric（布）: Cotton & Linen mixed（棉与亚麻混合） Leg: Birch wood（桦木） in Black Colorsize:560*660*920mm Packing : 1pcs/ctnPacking Size(CM):58*68(45)*94(63)1. Z-Frame out of Steel Tube（由钢管制成的Z型框架）2. Coated with PU（PU漆覆盖）3. Simply Structured and Easily ControlledThis kind of dining chair is made of steel tube frame, building board set inside as seat, coated with PU but exposed the part of touching Delivery Lead Time : 30-45 Days Minimum Order : 200Supply Ability : 5000 Pieces Per MonthCatalogueKind:Banquet ChairAppearance:ModernFolded:NoSize:450W*520d*920h MmFabric Color:Red and Yellow SpeckPaint Finished:GoldSize:450W*520D*920H mmMaterial:1. Aluminum tube（铝管） & Iron tube（铁管）:25*25*1.8 mm2. Foam（海绵）: Molded seated cushion with high density foam（坐垫造型是高密度海绵）3. Fabric（布）: 50% polyester（聚酯）, 50% cotton （棉）, vinyl（乙烯基） is available4. Paint（油漆） & Powder（搽粉）: Coated finished with scratch resistant（抗划伤）Weight Details(Aluminum):1. Net Weight: 5.0KG2. Gross Weight: 5.2KGPacking:Bubble bag packing the backrest and chair leg first, Then packing by plastic bag to avoid the hit.Loading:585PCS/1*20GP 1200PCS/1*40GP 1425PCS/1*40HC(HQ)Delivery Time:10-15days/1*20GP 15-20days/1*40GP 20-25days/1*40HC(HQ)size:510*590*850 / 530*465*835 sh450mmmaterial: fibreglass（玻璃纤维）+stainless steel（不锈钢） / ABS/chromed steel（烙钢）color:red / white packing:640*600*540 / 940*600*500 2pcs/ctnMaterial: plywwood shell（胶合木壳体） + steel frame（钢架）Color :optional Packing : 4pcs/ctnDelivery Lead Time : 45-60days Minimum Order : 200Supply Ability : 10000pcs/monthmade of mahoganywood high qualityfinishing antique（由高质量锈色处理的红木组成）size : 580 x 510 x 750mm Packing : 2 set per box Delivery Lead Time : 60days Minimum Order : 50Supply Ability : 200set/monthMaterail：metal and PU leather（铁+PU皮革）color：blacksize：H930*45*L460*W540mmtube size: 1.2mm steel tube thickness packing:4pcs/ctndelivery time:20 days after receiving depositeMOQ:30Material: fabric+high density foam +solid wood frame Color :golden Packing : 2pcs per ctnPackaging Size : 110 x 79 x 50 ( Centimeters )Delivery Lead Time : 60DAYS AFTER RECEIVED THE DEPOSITMinimum Order : 300pcsSupply Ability : 10000 per weekType: Dining Room Furniture Specific Use: Dining ChairGeneral Use: Home Furniture Material: WoodenWood Style: Solid Wood(实木）Wood Type: Rubber wood （橡胶木）Appearance: ModernFolded: NoSize: 420x510x860mm Packing : PE（聚乙烯）/Plastic wrapping, Carton box, Palletizing （托盘包装）.Delivery Lead Time : 30-45 days Minimum Order : 200 pcsSupply Ability : 10,000 pcsmake OEM and ODM serviceRaw material and final products are all under the international E1 standard Packing : 2 pcs/ carton Packaging Size（mm) : 400 x 500 x 775Package Weight : 14 ( Kilograms ) Minimum Order : 100pcsSupply Ability : 100000pcs/monthChrome-plated metal(烙铁） legs PU/PVC Seat in Various Colors Size: 630 x 420 x 980mmSimple design,Srong StructureMaterial:Metal tube（铁管）Aluminum alloy（铝合金）, stainless steel（不锈钢）, MDF（中密度纤维板） or chrome tube （镀烙管）Perfect polish on welding（焊接处完美光滑）Superior in fit, form & function （适用，形式，功能上乘）File format in DWG, DXF, ProE and STEP is acceptedOEM orders acceptedOxidation and wear resistanceCustomized colors are accepted Packing : 2 pieceS/cartons Packaging Size : 63 x 42 x 98 ( Centimeters )Delivery Lead Time : 30 days Minimum Order : 200 pieces Supply Ability : 200000pieces/MonthSolid wood（实木）Antique finish styleFabric upholstery（装饰布）Assembled package in exported standard cartonProduct image。

经典中英对照 ICH CTD 目录 Module 1, 2, 3, 4, 5

Module 1: Administrative Information and Prescribing Information1.1 Table of Contents of the Submission Including Module1.2 Documents Specific to Each Region (for example, application forms, prescribing information)Module 2: Common Technical Document Summaries2.1 Common Technical Document Table of Contents (Modules 2-5)2.2 CTD Introduction2.3 Quality Overall Summary(QOS) 质量综述INTRODUCTION2.3.S DRUG SUBSTANCE (NAME, MANUFACTURER) 原料药2.3.S.1 General Information (name, manufacturer) 基本信息2.3.S.2 Manufacture (name, manufacturer) 生产2.3.S.3 Characterisation (name, manufacturer) 特性鉴定2.3.S.4 Control of Drug Substance (name, manufacturer) 料药的质量控制2.3.S.5 Reference Standards or Materials (name, manufacturer) 对照品2.3.S.6 Container Closure System (name, manufacturer) 包装系统2.3.S.7 Stability (name, manufacturer).稳定性2.3.P DRUG PRODUCT (NAME, DOSAGE FORM) 制剂2.3.P.1 Description and Composition of the Drug Product (name, dosage form) 剂型及产品组成2.3.P.2 Pharmaceutical Development (name, dosage form) 产品开发2.3.P.3 Manufacture (name, dosage form) 生产2.3.P.4 Control of Excipients (name, dosage form)辅料的控制2.3.P.5 Control of Drug Product (name, dosage form) 制剂的质量控制2.3.P.6 Reference Standards or Materials (name, dosage form)对照品2.3.P.7 Container Closure System (name, dosage form) 包装系统2.3.P.8 Stability (name, dosage form)稳定性2.3.A APPENDICES 附录2.3.A.1 Facilities and Equipment (name, manufacturer) 设施和设备2.3.A.2 Adventitious Agents Safety Evaluation (name, dosage form, manufacturer) 外源因子的安全性评价2.3.A.3 Excipients 辅料2.3.R REGIONAL INFORMATION 区域性信息2.4 Nonclinical Overview2.4.1 Overview of the nonclinical testing strategy2.4.2 Pharmacology2.4.3 Pharmacokinetics2.4.4 Toxicology2.4.5 Integrated overview and conclusions2.4.6 List of literature references2.5 Clinical Overview2.5.1 Product Development Rationale2.5.2 Overview of Biopharmaceutics2.5.3 Overview of Clinical Pharmacology2.5.4 Overview of Efficacy2.5.5 Overview of Safety2.5.6 Benefits and Risks Conclusions2.5.7 Literature References2.6 Nonclinical Written and Tabulated SummariesPharmacologyPharmacokineticsToxicology2.6.1 Introduction2.6.2 Pharmacology Written Summary2.6.2.1 Brief Summary2.6.2.2 Primary Pharmacodynamics2.6.2.3 Secondary Pharmacodynamics2.6.2.4 Safety Pharmacology2.6.2.5 Pharmacodynamic Drug Interactions2.6.2.6 Discussion and Conclusions2.6.2.7 Tables and Figures2.6.3 Pharmacology Tabulated Summary (see Appendix B)2.6.3.1 Pharmacology: Overview2.6.3.2 Primary Pharmacodynamics*2.6.3.3 Secondary Pharmacodynamics*2.6.3.4 Safety Pharmacology2.6.3.5 Pharmacodynamic Drug Interactions*2.6.4 Pharmacokinetics Written Summary2.6.4.1 Brief Summary2.6.4.2 Methods of Analysis2.6.4.3 Absorption2.6.4.4 Distribution2.6.4.5 Metabolism (interspecies comparison)2.6.4.6 Excretion2.6.4.7 Pharmacokinetic Drug Interactions2.6.4.8 Other Pharmacokinetic Studies2.6.4.9 Discussion and Conclusions2.6.4.10 Tables and Figures2.6.5 Pharmacokinetics Tabulated Summary (see Appendix B)2.6.5.1 Pharmacokinetics: Overview2.6.5.2 Analytical Methods and Validation Reports*2.6.5.3 Pharmacokinetics: Absorption after a Single Dose2.6.5.4 Pharmacokinetics: Absorption after Repeated Doses2.6.5.5 Pharmacokinetics: Organ Distribution2.6.5.6 Pharmacokinetics: Plasma Protein Binding2.6.5.7 Pharmacokinetics: Study in Pregnant or Nursing Animals2.6.5.8 Pharmacokinetics: Other Distribution Study2.6.5.9 Pharmacokinetics: Metabolism In Vivo2.6.5.10 Pharmacokinetics: Metabolism In Vitro2.6.5.11 Pharmacokinetics: Possible Metabolic Pathways2.6.5.12 Pharmacokinetics: Induction/Inhibition of Drug-Metabolizing Enzymes 2.6.5.13 Pharmacokinetics: Excretion2.6.5.14 Pharmacokinetics: Excretion into Bile2.6.5.15 Pharmacokinetics: Drug-Drug Interactions2.6.5.16 Pharmacokinetics: Other2.6.6 Toxicology Written Summary2.6.6.1 Brief Summary2.6.6.2 Single-Dose Toxicity2.6.6.3 Repeat-Dose Toxicity (including supportive toxicokinetics evaluation)2.6.6.4 Genotoxicity2.6.6.5 Carcinogenicity (including supportive toxicokinetics evaluations)2.6.6.6 Reproductive and Developmental Toxicity (including range-finding studies and supportive toxicokinetics evaluations)2.6.6.7 Local Tolerance2.6.6.8 Other Toxicity Studies (if available)2.6.6.9 Discussion and Conclusions2.6.6.10 Tables and Figures2.6.7 Toxicology Tabulated Summary (see Appendix B)2.6.7.1 Toxicology: Overview2.6.7.2 Toxicokinetics: Overview of Toxicokinetics Studies2.6.7.3 Toxicokinetics: Overview of Toxicokinetics Data2.6.7.4 Toxicology: Drug Substance2.6.7.5 Single-Dose Toxicity2.6.7.6 Repeat-Dose Toxicity: Non-Pivotal Studies2.6.7.7 Repeat-Dose Toxicity: Pivotal Studies2.6.7.8 Genotoxicity: In Vitro2.6.7.9 Genotoxicity: In Vivo2.6.7.10 Carcinogenicity2.6.7.11 Reproductive and Developmental Toxicity: Non-Pivotal Studies2.6.7.12 Reproductive and Developmental Toxicity – Fertility and Early Embryonic Development to Implantation (Pivotal)2.6.7.13 Reproductive and Developmental Toxicity –Effects on Embryo-Fetal Development (Pivotal)2.6.7.14 Reproductive and Developmental Toxicity –Effects on Pre- and Postnatal Development, Including Maternal Function (Pivotal)2.6.7.15 Studies in Juvenile Animalsa2.6.7.16 Local Tolerance2.6.7.17 Other Toxicity Studies2.7 Clinical Summary2.7.1 Summary of Biopharmaceutic Studies and Associated Analytical Methods 2.7.1.1 Background and Overview2.7.1.2 Summary of Results of Individual Studies2.7.1.3 Comparison and Analyses of Results Across Studies2.7.1.4 Appendix2.7.2 Summary of Clinical Pharmacology Studies2.7.2.1 Background and Overview2.7.2.2 Summary of Results of Individual Studies2.7.2.3 Comparison and Analyses of Results Across Studies2.7.2.4 Special Studies2.7.2.5 Appendix2.7.3 Summary of Clinical Efficacy2.7.3.1 Background and Overview of Clinical Efficacy2.7.3.2 Summary of Results of Individual Studies2.7.3.3 Comparison and Analyses of Results Across Studies2.7.3.3.1 Study Populations2.7.3.3.2 Comparison of Efficacy Results of all Studies2.7.3.3.3 Comparison of Results in Sub-populations2.7.3.4 Analysis of Clinical Information Relevant to Dosing Recommendations2.7.3.5 Persistence of Efficacy and/or Tolerance Effects2.7.3.6 Appendix2.7.4 Summary of Clinical Safety2.7.4.1 Exposure to the Drug2.7.4.1.1 Overall Safety Evaluation Plan and Narratives of Safety Studies2.7.4.1.2 Overall Extent of Exposure2.7.4.1.3 Demographic and Other Characteristics of Study Population2.7.4.2 Adverse Events2.7.4.2.1 Analysis of Adverse Events2.7.4.2.2 Narratives2.7.4.3 Clinical Laboratory Evaluations2.7.4.4 Vital Signs, Physical Findings, and Other Observations Related to Safety2.7.4.5 Safety in Special Groups and Situations2.7.4.5.1 Intrinsic Factors2.7.4.5.2 Extrinsic Factors2.7.4.5.3 Drug Interactions2.7.4.5.4 Use in Pregnancy and Lactation2.7.4.5.5 Overdose2.7.4.5.6 Drug Abuse2.7.4.5.7 Withdrawal and Rebound2.7.4.5.8 Effects on Ability to Drive or Operate Machinery or Impairment of Mental Ability2.7.4.6 Post-marketing Data2.7.4.7 Appendix2.7.5 Literature References2.7.6 Synopses of Individual StudiesModule 3: Quality3.1 Table of Contents of Module 33.2 Body of Data(数据汇总)3.2.S DRUG SUBSTANCE (NAME, MANUFACTURER) 原料药3.2.S.1 General Information (name, manufacturer) 基本信息3.2.S.1.1 Nomenclature (name, manufacturer) 药品名称3.2.S.1.2 Structure (name, manufacturer) 结构3.2.S.1.3 General Properties (name, manufacturer) 基本性质3.2.S.2 Manufacture (name, manufacturer) 生产3.2.S.2.1 Manufacturer(s) (name, manufacturer) 生产商3.2.S.2.2 Description of Manufacturing Process and Process Controls (name, manufacturer) 生产工艺和工艺控制3.2.S.2.3 Control of Materials (name, manufacturer) 物料控制3.2.S.2.4 Controls of Critical Steps and Intermediates (name, manufacturer) 关键步骤和中间体的控制3.2.S.2.5 Process Validation and/or Evaluation (name, manufacturer) 工艺验证和/或评价3.2.S.2.6 Manufacturing Process Development (name, manufacturer) 生产工艺的开发3.2.S.3 Characterisation (name, manufacturer) 特性鉴定3.2.S.3.1 Elucidation of Structure and other Characteristics (name, manufacturer) 结构和理化性质3.2.S.3.2 Impurities (name, manufacturer) 杂质3.2.S.4 Control of Drug Substance (name, manufacturer) 原料药的质量控制3.2.S.4.1 Specification (name, manufacturer) 质量标准3.2.S.4.2 Analytical Procedures (name, manufacturer) 分析方法3.2.S.4.3 Validation of Analytical Procedures (name, manufacturer) 分析方法的验证3.2.S.4.4 Batch Analyses (name, manufacturer) 批分析3.2.S.4.5 Justification of Specification (name, manufacturer) 质量标准制定依据3.2.S.5 Reference Standards or Materials (name, manufacturer)对照品/标准品3.2.S.6 Container Closure System (name, manufacturer) 包装系统3.2.S.7 Stability (name, manufacturer) 稳定性3.2.S.7.1 Stability Summary and Conclusions (name, manufacturer) 稳定性总结和结论3.2.S.7.2 Post-approval Stability Protocol and Stability Commitment (name, manufacturer) 批准后稳定性研究方案和承诺3.2.S.7.3 Stability Data (name, manufacturer)稳定性数据3.2.P DRUG PRODUCT (NAME, DOSAGE FORM) 制剂3.2.P.1 Description and Composition of the Drug Product (name, dosage form)剂型及产品组成3.2.P.2 Pharmaceutical Development (name, dosage form) 产品开发3.2.P.2.1 Components of the Drug Product (name, dosage form) 处方组成3.2.P.2.1.1 Drug Substance (name, dosage form) 原料药3.2.P.2.1.2 Excipients (name, dosage form)辅料3.2.P.2.2 Drug Product (name, dosage form)制剂3.2.P.2.2.1 Formulation Development (name, dosage form)处方开发过程3.2.P.2.2.2 Overages (name, dosage form)过量投料3.2.P.2.2.3 Physicochemical and Biological Properties (name, dosage form)制剂相关特性3.2.P.2.3 Manufacturing Process Development (name, dosage form)生产工艺的开发3.2.P.2.4 Container Closure System (name, dosage form)包装系统3.2.P.2.5 Microbiological Attributes (name, dosage form)微生物属性3.2.P.2.6 Compatibility (name, dosage form)相容性3.2.P.3 Manufacture (name, dosage form)生产3.2.P.3.1 Manufacturer(s) (name, dosage form)生产商3.2.P.3.2 Batch Formula (name, dosage form)批处方3.2.P.3.3 Description of Manufacturing Process and Process Controls (name, dosage form)生产工艺和工艺控制3.2.P.3.4 Controls of Critical Steps and Intermediates (name, dosage form)关键步骤和中间体的控制3.2.P.3.5 Process Validation and/or Evaluation (name, dosage form)工艺验证和/或评价3.2.P.4 Control of Excipients (name, dosage form) 辅料的控制3.2.P.4.1 Specifications (name, dosage form)质量标准3.2.P.4.2 Analytical Procedures (name, dosage form)分析方法3.2.P.4.3 Validation of Analytical Procedures (name, dosage form)分析方法的验证3.2.P.4.4 Justification of Specifications (name, dosage form)质量标准制定依据3.2.P.4.5 Excipients of Human or Animal Origin (name, dosage form)人源或动物源辅料3.2.P.4.6 Novel Excipients (name, dosage form)新型辅料3.2.P.5 Control of Drug Product (name, dosage form)制剂的质量控制3.2.P.5.1 Specification(s) (name, dosage form)质量标准3.2.P.5.2 Analytical Procedures (name, dosage form)分析方法3.2.P.5.3 Validation of Analytical Procedures (name, dosage form)分析方法的验证3.2.P.5.4 Batch Analyses (name, dosage form)批分析3.2.P.5.5 Characterisation of Impurities (name, dosage form)杂质分析3.2.P.5.6 Justification of Specification(s) (name, dosage form)质量标准制定依据3.2.P.6 Reference Standards or Materials (name, dosage form)对照品/标准品3.2.P.7 Container Closure System (name, dosage form)包装系统3.2.P.8 Stability (name, dosage form) 稳定性3.2.P.8.1 Stability Summary and Conclusion (name, dosage form)稳定性总结和结论3.2.P.8.2 Post-approval Stability Protocol and Stability Commitment (name, dosage form)批准后稳定性研究方案和承诺3.2.P.8.3 Stability Data (name, dosage form)稳定性数据3.2.A APPENDICES附录3.2.A.1 Facilities and Equipment (name, manufacturer)设施和设备3.2.A.2 Adventitious Agents Safety Evaluation (name, dosage form, manufacturer)外源因子的安全性评价3.2.A.3 Excipients辅料3.2.R REGIONAL INFORMATION区域性信息3.3 Literature References参考文献Module 4: Nonclinical Study Reports4.1 Table of Contents of Module 44.2 Study Reports(见正文)4.2.1 Pharmacology4.2.1.1 Primary Pharmacodynamics4.2.1.2 Secondary Pharmacodynamics4.2.1.3 Safety Pharmacology4.2.1.4 Pharmacodynamic Drug Interactions4.2.2 Pharmacokinetics4.2.2.1 Analytical Methods and Validation Reports (if separate reports are available) 4.2.2.2 Absorption4.2.2.3 Distribution4.2.2.4 Metabolism4 2.2.5 Excretion4.2.2.6 Pharmacokinetic Drug Interactions (nonclinical)4.2.2.7 Other Pharmacokinetic Studies4.2.3 Toxicology4.2.3.1 Single-Dose Toxicity (in order by species, by route)4.2.3.2 Repeat-Dose Toxicity (in order by species, by route, by duration; including supportive toxicokinetics evaluations)4.2.3.3 Genotoxicity4.2.3.3.1 In vitro4.2.3.3.2 In vivo (including supportive toxicokinetics evaluations)4.2.3.4 Carcinogenicity (including supportive toxicokinetics evaluations)4.2.3.4.1 Long-term studies (in order by species; including range-finding studies that cannot appropriately be included under repeat-dose toxicity or pharmacokinetics)4.2.3.4.2 Short- or medium-term studies (including range-finding studies that cannot appropriately be included under repeat-dose toxicity or pharmacokinetics)4.2.3.4.3 Other studies4.2.3.5 Reproductive and Developmental Toxicity (including range-finding studies and supportive toxicokinetics evaluations) (If modified study designs are used, the following sub-headings should be modified accordingly.)4.2.3.5.1 Fertility and early embryonic development4.2.3.5.2 Embryo-fetal development4.2.3.5.3 Prenatal and postnatal development, including maternal function4.2.3.5.4 Studies in which the offspring (juvenile animals) are dosed and/or further evaluated.4.2.3.6 Local Tolerance4.2.3.7 Other Toxicity Studies (if available)4.2.3.7.1 Antigenicity4.2.3.7.2 Immunotoxicity4.2.3.7.3 Mechanistic studies (if not included elsewhere)4.2.3.7.4 Dependence4.2.3.7.5 Metabolites4.2.3.7.6 Impurities4.2.3.7.7 Other4.3 Literature ReferencesModule 5: Clinical Study Reports5.1 Table of Contents of Module 55.2 Tabular Listing of All Clinical Studies5.3 Clinical Study Reports5.3.1 Reports of Biopharmaceutic Studies5.3.1.1 Bioavailability (BA) Study Reports5.3.1.2 Comparative BA and Bioequivalence (BE) Study Reports5.3.1.3 In Vitro – In Vivo Correlation Study Reports5.3.1.4 Reports of Bioanalytical and Analytical Methods for Human Studies5.3.2 Reports of Studies Pertinent to Pharmacokinetics Using Human Biomaterials5.3.2.1 Plasma Protein Binding Study Reports5.3.2.2 Reports of Hepatic Metabolism and Drug Interaction Studies5.3.2.3 Reports of Studies Using Other Human Biomaterials5.3.3 Reports of Human Pharmacokinetic (PK) Studies5.3.3.1 Healthy Subject PK and Initial Tolerability Study Reports5.3.3.2 Patient PK and Initial Tolerability Study Reports5.3.3.3 Intrinsic Factor PK Study Reports5.3.3.4 Extrinsic Factor PK Study Reports5.3.3.5 Population PK Study Reports5.3.4 Reports of Human Pharmacodynamic (PD) Studies5.3.4.1 Healthy Subject PD and PK/PD Study Reports5.3.4.2 Patient PD and PK/PD Study Reports5.3.5 Reports of Efficacy and Safety Studies5.3.5.1 Study Reports of Controlled Clinical Studies Pertinent to the Claimed Indication5.3.5.2 Study Reports of Uncontrolled Clinical Studies5.3.5.3 Reports of Analyses of Data from More than One Study5.3.5.4 Other Study Reports5.3.6 Reports of Post-Marketing Experience5.3.7 Case Report Forms and Individual Patient Listings5.4 Literature ReferencesANNEX : Granularity Document参考ICH guidelines：M4E R1M4Q R1M4S R2。

英文附录部分

Moore’s Law, named after Intel co-founder Gordon Moore, is the idea that processing power for computers will double every two years. This has proven to be valid in many areas, from components (the initial scope) to devices. In particular, the relentless rise of chip power and the striking fall in costs have finally made it possible for devices everywhere to have some form of “intelligence” embedded in them. We have advanced from mainframes to workstations, to client-server, to grid computing, to cloud computing and, today, the next natural step is the Internet of Things. Smart devices, active devices, all around the world are connected, generating huge amounts of data and reacting to measures or commands from central or distributed authorities Gartner predicts that there will be 26 billion IoT devices installed in 2020, that they will generate $300 billion in revenue for hardware manufactures, and that the overall impact on the economy will be around $1.9 trillion.This proliferation of data thanks to the IoT can be daunting, but its strength is that it enables all new fields of applications, in particular around big data. Organizations are very eager to tap into this new market and its opportunities, but are a bit nervous about taking this first step. When entering a new field of activities, very often there is an associated learning curve and barrier to entry. Fortunately, with the Internet of Things, it’s not as complex or expensive as it seems. This hardware evolution, which has quietly crept up on us, can be managed by leveraging another technology evolution of equally enormous proportions: open source software.Related Vendor ContentOpen source software has been around for several decades, now, and is defined by the four freedoms it brings to the user:1．The freedom to run the program as you wish, for any purpose (freedom 0).2．The freedom to study how the program works and change it so it does your computing as you wish (freedom 1). Access to the source code is a precondition for this.3．The freedom to redistribute copies so you can help your neighbour (freedom 2).4．The freedom to distribute copies of your modified versions to others (freedom 3).By doing this you can give the whole community a chance to benefit from your changes. Access to the source code is a precondition for this.These four freedoms are the reason open source is also referred to as free software. By enabling and encouraging sharing of source code, they allow the user to be as creative as wanted and to craft applications that would otherwise be impossible to build from scratch. And, as more people develop and execute these creative new applications, they inspire even more new ideas and projects –with open source software all of these new ideas and ways to improve existing applications can be brought to fruition much faster than ever before. And “fast” is central to the IoT.IoT is the world of DevOps and other agile software (and hardware) development methodologies. The faster a team can come up with an idea for a product, develop it, sell it at a low price but with a good margin, and iteratively enhance it, the better it is. And now, with hundreds and even thousands of developers and teams creating newIoT products, every group or project involved is exponentially increasing the number of new devices, new sources of data, and, as a consequence, the number of applications to run all of this.The zero entry barrier provided by the use of open source, with several toolkits, libraries, and open source hardware like Arduino and Raspberry Pi, is the foundation for it turning up in small devices sprinkled all over the globe, from home security to energy management systems, from automobile telematics to health monitors. Because open source helps lower the cost of the device itself, companies can now experiment and stitch together solutions that would otherwise have been ignored because they would have required upfront purchasing of expensive licenses for development tools and environments, specific libraries and software components. Open source is a very effective way to ride the IoT wave at high speed while keeping the risks and costs to do so under control.Open source can bring together data from thousands of sensors and devices distributed around the planet, and this enables creativity and innovation in new ways. This data makes the IoT incredibly exciting and promising for organizations and individual developers alike. It can be used to develop internal tools, components of existing bigger systems (like measuring sensors for larger machines) or standalone products (think home automation sensors or environmental sensors). Actually, a survey that was conducted by ARM shows that close to 75% of organizations already use IoT in one way or another, or are currently exploring ways to do so.Bill Joy, co-founder of Sun Microsystems once noted that “innovation happe ns elsewhere”. That sentence either implies getting ideas from other places (acquisitions, hiring external talent, or conducting open-innovation workshops) or by sharing ideas with a community of people with similar interests. Open source is by far the best way to develop in such a shared mode, by hosting your code in a publicly accessible repository where not just one entity writes code, but anybody can connect to the repository, check out parts of the code, and contribute modifications, or additions to the code commons. That way, there is no limit to where the innovation comes from, or how fast it is driven by very motivated contributors.Open source is also a fantastic tool to bridge the digital divide. It is very easy to start developing applications with IoT systems such as Arduino or Raspberry Pi, which are built fully on open source. It’s easy to simply purchase the hardware, or alternatively, just download the schematics and build it directly. These systems come with free, open source operating systems like Contiki, or Raspian, development kits such as the Eclipse IoT Project, middleware like IoTSys and all kinds of interfaces to connect to hardware sensors and equipment. Anybody can start prototyping IoT devices, and then turn them into full-fledged products. People have been using these platforms to create monitoring devices for their aquariums, gardens or spas or to build weather stations and control modules for all kinds of systems like garage doors, thermostats or coffee pots that suddenly become fully automated and autonomous, also providing active feedback on their environment.Open source and the Internet of Things, when combined, can help bring innovation and knowledge into any kind of society in both the developed and the developingworld. For example, innovators in the Amazon rainforest, even though they only had access to obsolete hardware, were able to implement an open source infrastructure and capitalize on the Internet of Things to develop an application that allowed them to use old cellphones powered by discarded solar panels to listen to sounds in very remote parts of the rainforest. Then, they were able, through sound processing and pattern recognition to decipher which noises were made by chain saws. This application, built using freely available open source libraries, allowed these innovators to alert officials to the illegal deforestation taking place and protect the rainforest.Normally, proprietary databases, due to expensive licensing costs, tend to raise entry barrier to being able to collecting, store, and process data required by such projects. But when using open source, there are a variety of easy and accessible open source databases such as MongoDB, MySQL/MariaDB, PostgreSQL and Cassandra (to name just a few) that help manage data at a lower cost and help developers accelerate project timelines. Tools to manage the data have also surfaced, including Redis, which helps enhance the usability of open source databases. This wouldn’t be possible without open source software – because open source is accessible for all, developers with great ideas don’t need to go and re-invent every spoke of the wheel. With open source they can just tap into pre-existing open source libraries, and with some customization, modifying and improving the code they can tailor (then, interestingly, contribute it back to the community).Startups are already creating the IoT future, building wearable devices that can sense the environment – air composition, microbial content, suspended particulate matter, and matching it with a vast array of public databases in real time to tell the wearer, “Leave now –the air has traces of the Ebola virus.” To do this, they leverage existing open source libraries and tools, in addition to their own intellectual property. They create new devices that live in the IoT and provide very high value add. Venture capitalists (True Ventures, Kleiner Perkins…), and corporate venture funds (Intel, Qualcomm, Cisco…) know this and are investing heavily in these markets. Open source holds tremendous promise for enterprises acquiring IoT infrastructure.Since there are no real constraints in terms of numbers of devices, volumes of data, consolidated bandwidth, the only limit, with IoT, is your imagination. So what are you waiting for? Go get a kit, and start developing IoT applications.。

英语作文目录模板

英语作文目录模板Table of Contents。

1. Introduction。

2. Importance of a Table of Contents。

3. Elements of a Table of Contents。

4. How to Create a Table of Contents。

5. Tips for Creating an Effective Table of Contents。

6. Conclusion。

Introduction。

A table of contents is a crucial component of any document, whether it is a book, report, or research paper. It provides a roadmap for the reader, allowing them to quickly locate specific sections and navigate through the document with ease. In this article, we will explore the importance of a table of contents, the key elements it should include, and how to create an effective one.Importance of a Table of Contents。

A table of contents serves several important purposes. First and foremost, it helps the reader to quickly find the information they are looking for within a document. This is especially useful in lengthy documents, where locating specific sections can be time-consuming without a table of contents.Additionally, a table of contents provides a high-level overview of the document's structure and organization. This can be particularly helpful for readers who want to understand the scope of the document before diving into the details.Furthermore, a well-structured table of contents can enhance the overall professionalism and readability of a document. It shows that the author has taken the time to organize their work in a clear and logical manner, which can make a positive impression on the reader.Elements of a Table of Contents。

附录3参考文献译文本示例(20150316).

附录3：（封面、封底用浅蓝色封面纸（卡纸）打印，此面为封面正面）本科生毕业设计（论文）参考文献译文本译文出处：院系_______________________专业班级_______________________姓名_______________________学号_______________________指导教师_______________________年月译文要求（封面、封底用浅蓝色封面纸（卡纸）打印，此面为封面背面）一、译文内容须与课题（或专业内容）联系，并需在封面注明详细出处。

二、出处格式为图书：作者.书名.版本（第×版）.译者.出版地：出版者，出版年.起页～止页期刊：作者.文章名称.期刊名称，年号，卷号（期号）：起页～止页三、译文不少于5000汉字（或2万印刷符）。

四、翻译内容用五号宋体字编辑，采用A4号纸双面打印，封面与封底采用浅蓝色封面纸（卡纸）打印。

要求内容明确，语句通顺。

五、译文及其相应参考文献一起装订，顺序依次为封面、译文、文献。

六、翻译应在第七学期完成。

译文评阅导师评语应根据学校“译文要求”，对学生译文翻译的准确性、翻译数量以及译文的文字表述情况等做具体的评价后，再评分。

评分：___________________（百分制）指导教师（签名）：___________________年月日有关匿名比特币的相关研究及未来发展的挑战摘要：自从2009比特币问世后，它现如今已经发展成为最成功的数字加密货币。

除了因为比特币的高安全性和稳定性之外，它的匿名性和分布式的特点或许也是其成功的关键。

在这篇文章中，我们将就使得这种数字加密货币在个人隐私领域成为一种极具有研究价值的话题的原因进行全面阐释。

我们对到目前为止发表的所有有关匿名比特币的研究文献进行了详细的回顾，同时我们将列举一些相关的研究难点。

1.引言比特币是一种基于公钥密码系统的网络虚拟货币，它是由中本聪（化名）在其08年撰写的论文中提出的，并最终在2009年1月正式问世。

产品目录英文版

产品目录套筒FERRULE00TF0FERRULE FOR TEFLON HOSE00018FERRULE FOR SAE 100R7 HOSE00110-AFERRULE FOR SAE 100AT/EN 853 1SN HOSE00210FERRULE FOR SAE 100 R2AT /DIN20022 2SN00400FERRULE FOR4SP、4SH/12-16、R12/06-16 HOSE00401FERRULE FOR 4SH、R12/32 HOSE00402FERRULE FOR SAE 100R9AT-R12, EN856-4SP/04-16 HOSE00403FERRULE FOR EN 856-4SP HOSE00500FERRUEL FOR SAE 100 R5 HOSE00621INTERLOCK FERRUKE FOR GB/T 10544R13/SAE 100R13/EN856 R1303310FERRULE FOR SAE 100 R2AT/EN 853 2SN HOSE 扣压式软管接头SWAGED HOSE FITTING10411METRIC MALE 24°CONE SEAT L.T.DIN 3853.T.ISO 8434-1—DIN 386110511METRIC MALE 24° CONE SEAT H.T. ISO 8434-1—DIN 386110611METRIC MALE 60° CONE SEAT 10711GB METRIC MAL E 74°CONE10811METRIC MALE 90°CONE12211BSPPMALE O-RING12611BSPP MALE 60°CONE SEAT12611ABSPP MALE DOUBLE USE FOR 60°CONE SEAT OR BONDED SEAL 13011-SPBSPT MALE15611NPT MALE16011SAE MALE CONE O-RINGISO 11932-SAE J192617811SAE MALE 90°CONE20111METRIC FEMALE MULTISEAL2014145°METRIC FEMALE MULTISEAL2019190 °METRIC FEMALE MULTISEAL20211METRIC FEMALE FLAT SEAT2023130°METRIC FEMALE FLAT SEAT2024145°METRIC FEMALE FLAT SEAT2029190°METRIC FEMALE FLAT SEAT20411METRIC FEMALE 24° CONE O-RING L.T.DIN 38652044145°METRIC FEMALE 24°CONE O-RING L.T.DIN38652049190°METRIC FEMALE 24°CONE O-RING L.T.ISO 12151-2—DIN386520511METRIC FEMALE 24°CONE O-RING H.T.DIN38652054145°METRIC FEMALE 24°CONE O-RING H.T.DIN38652059190°METRIC FEMALE 24° CONE O-=RING H.T.DIN3865 20611METRIC FEMALE 60°CONE2064145°METRIC FEMALE 60°CONE2069190°METRIC FEMALE 60°CONE20711GB METRIC FEMALE 74°CONE SEAT2074145°GB METRIC FEMALE 74°CONE SEAT2079190°GB METRIC FEMALE 74°CONE SEAT22111METRIC FEMALE FLAT SEAT2023130°METRIC FEMALE FLAT SEAT2024145°METRIC FEMALE FLAT SEAT2029190°METRIC FEMALE FLAT SEAT20411METRIC FEMALE 24° CONE O-RING L.T.DIN 38652049190°METRIC FEMALE 24°CONE O-RING L.T.ISO 12151-2—DIN386520511METRIC FEMALE 24°CONE O-RING H.T.DIN38652054145°METRIC FEMALE 24°CONE O-RING H.T.DIN38652059190°METRIC FEMALE 24° CONE O-=RING H.T.DIN386520611METRIC FEMALE 60°CONE2064145°METRIC FEMALE 60°CONE2069190°METRIC FEMALE 60°CONE20711GB METRIC FEMALE 74°CONE SEAT2074145°GB METRIC FEMALE 74°CONE SEAT2079190°GB METRIC FEMALE 74°CONE SEAT22111BSPP FEMALE MULISEAL2214145°BSPP FEMALE MULTISEAL2219190°BSPP FEMALE MULTISEAL22211BSPP FEMALE FLAT SEAT2224145°BSPP FEMALE FLAT SEAT2229190°BBSP FEMALE SEAT22611BSPP FEMALE 60°CONE22611-DBSPP FEMALE 60°CONE DOUBLE HEXAGON22611-SMBSPP FEMALE 60°CONE DOUBLE HEXAGON2264145°BSPP FEMALE 60°CONE2269190°BSPP FEMALE 60° CONE22691-T90°BSPP FEMALE 60° CONE24211ORFS FEMALL FLAT SEAT ISO 12151-1°—SAE J516 2424145° ORFS FEMALE FLAT SEAT ISO12151—SAE J5162429190°ORFS FEMALE FLAT SEAT ISO 12151-1—SAE J51626711JIC FEMALE 74°CONESEAT SAR J5142674145°JIC FEMALE 74°CONE SEAT SAE J5142679190°JIC FEMALE 74°CONESEAT SAE J5148739190°SAR FLANGE 3000 PSI87611SAE FLANGE 6000 PSIISO 12151-3—SAE J5168764145° SAR FLANGE 6000 PSI ISO 12151-3—SAE J51688111JIS FLANGE8814145°JIS FLANGE8819190°JIS FLANGE法兰夹FLANGE CLAMPSFLISO 6162-1—SAE J518L-SERIES SPLIT FLANGE CLAMPSFSISO 6162-2—SAE J518S-SERIES SPLIT FLANGE CLAMPS。

附录3-英文目录示例

附录3 英文目录示例CONTENTS（新罗马2号字，大写，加粗，居中）（Abstract in Chinese、Acknowledgement等和一级标题为新罗马5号字粗体，二级标题为新罗马5号字）Abstract in Chinese (I)Abstract in English (Ⅱ)1.Introduction (1)1.1 Aims of research (1)1.2 Total document (2)1.2.1 Concept of soilless culture (2)2.Materials and Methods (14)2.1 Materials and methods in sugar beet with different soilless culture (14)2.1.1 Experimental materials (14)2.1.2 Experimental methods (14)2.2 Materials and methods on the effect of environmental factors to NRand GS activators in sugar beet seedling with soilless culture (15)2.2.1 Experimental materials (15)2.2.2 Experimental methods (16)2.2.3 Determination methods (18)3.Results analysis (20)3.1 The compare to different methods in soilless culture (20)3.1.1 The compare to the viability rate of sugar beet seedlingtrasplated with difficlt methods in soilless cuture (20)3.1.2 The change tendencies of nitratase during seeding of sugar beetwithout different methods of cultivation without soil (20)3.2 The controlling law of N、T、Mg2+、pH to the NR vitalityin sugar beet leaf during with soilless culture (26)3.2.1 Model build (26)3.2.2 Monofactorial effector analysis (28)3.3 The controlling law of N、T、Mg2+、pH to the GS vitalityin sugar beet root during with soilless culture (33)3.3.1 Model build (34)3.3.2 Monofactorial effector analysis (35)4.Discussion (48)4.1 The compare to different methods in soilless culture (48)4.1.1 The compare to the viability rate of sugar beet seedlingtrasplated with difficlt methods in soilless cuture (48)4.1.2 The change of NR and GS during seedling of sugar beettrasplated with difficult methods in soilless culture (48)4.2 The effect of environmental factors to NR and GS activatorsin sugar beet seedling with soilless culture (50)4.2.1 The effect of N to the enzyme activator in sugar beet (50)4.2.2 The effect of T to the enzyme activity in sugar beet (50)5.Conclusion (54)Acknowledgement (55)References (56)Appendix (62)Papers published in the period of Ph.M. education (66)注：英文目录用词Abstract 摘要Introduction 绪论Conclusion 结论References 参考文献Appendix A,B … 附录A,BPapers published in the period of Ph.D. education攻读博士学位期间发表的论文Acknowledgement 致谢Index 索引Resume 个人简历。

lwgf

目录1 内容要求 (1)2 书写规范 (3)3 打印要求 (10)附录1 学位论文封面示例 (11)附录2 目录示例 (16)附录3 “物理量名称及符号表”示例 (17)附录4 “物理量名称及符号”示例 (18)附录5 中华人民共和国法定计量单位 (21)附录6 有关数字用法的规定 (25)附录7 插表示例 (26)附录8 有关电气图中图形符号、文字符号的国家标准 (27)附录9 索引示例 (28)附录10 页眉、页脚示例 (29)河北科技大学研究生学位论文撰写规范学位论文是研究生科学研究工作的全面总结，是描述其研究成果、代表其研究水平的重要学术文献资料，是申请和授予相应学位的基本依据。

学位论文撰写是研究生培养过程的基本训练之一，必须按照确定的规范认真执行。

指导教师应加强指导，严格把关。

论文撰写应符合国家及各专业部门制定的有关标准，符合汉语语法规范。

1 内容要求1.1 题目题目应恰当、简明、准确地反映本课题的研究内容，不设副标题。

1.2 摘要与关键词1.2.1 摘要摘要是论文内容的简要陈述，是一篇具有独立性和完整性的短文。

摘要应包括本论文的基本研究内容、研究方法、创造性成果及其理论与实际意义。

摘要中不宜使用公式、图表，不标注引用文献编号。

避免将摘要写成目录式的内容介绍。

1.2.2 关键词关键词是供检索用的主题词条，应采用能覆盖论文主要内容的通用技术词条（参照相应的技术术语标准）。

关键词一般列5～10个，按词条的外延层次从大到小排列。

1.3 论文正文论文正文包括绪论、论文主体及结论等部分。

1.3.1 绪论绪论一般作为第1章。

绪论应包括：本研究课题的学术背景及其理论与实际意义；国内外文献综述；相关领域的研究进展及成果、存在的不足或待深入研究的问题；本研究课题的来源及主要研究内容。

1.3.2 论文主体论文主体是学位论文的主要部分，应该结构合理，层次清楚，重点突出，文字简练、通顺。

论文主体的内容应包括以下各方面：本研究内容的总体方案设计与选择论证；本研究内容各部分（包括硬件与软件）的设计计算；本研究内容试验方案设计的可行性、有效性及试验数据处理及分析；本研究内容的理论分析；对本研究内容及成果应进行较全面、客观的理论阐述，应着重指出本研究内容中的创新、改进与实际应用之处。

英文商务合同chp3

• • • • •
1 货号 Article No. 2 品名及规格 Description&Specification 3 数量 Quantity 4 单价 Unit Price 5 总值：数量及总值均有_____%的增减,由卖方决定。 Total Amount With _____% more or less both in amount and quantity allowed at the sellers option. • 6 生产国和制造厂家 Country of Origin and Manufacturer • 7包装： Packing： • 8 唛头： Shipping Marks：
• • • •

9 装运期限：Time of Shipment： 10装运口岸：Port of Loading： 11目的口岸：Port of Destination： 12保险：由卖方按发票全额110%投保至_____为止的_____险。 Insurance： To be effected by buyers for 110% of full invoice value covering _____ up to _____ only. • 13付款条件：买方须于_____年_____月_____日将保兑的，不可撤销的，可转让可分割的即期信用证开到卖方。信用证议付有效期延至上列装运期后15天在中国到期，该信用证中必须注明允许分运及转运。 Payment： By confirmed, irrevocable, transferable and divisible L/C to be available by sight draft to reach the sellers before ___/___/_____ and to remain valid for ingotiation in China until 15 days after the aforesaid time of shipment. Tje L/C must specify that transhipment and partial shipments are allowed. • 14单据：Documents： • 15装运条件：Terms of Shipment： • 16品质与数量、重量的异义与索赔：Quality/Quantity Discrepancy and Claim：

英语作文目录模板

英语作文目录模板英文回答：Abstract。

This comprehensive report presents a thorough analysisof the key findings and implications of a recent study exploring the impact of social media on mental well-being. The study employed a mixed-methods approach, combining quantitative and qualitative data collection techniques, to gain a nuanced understanding of the complex relationship between social media use and mental health outcomes.Introduction。

Social media has become an integral part of modern life, with billions of users worldwide. While it offers numerous benefits, such as increased connectivity, information sharing, and entertainment, concerns have been raised regarding its potential negative consequences on mentalwell-being. This study aimed to investigate the following research questions:What are the associations between different types of social media use and mental health outcomes?How do individual factors, such as personality traits and coping mechanisms, moderate these associations?What are the potential implications for mental health interventions and public health policy?Methods。

附录3.pdf[共4页]

附录3 连锁经营名词、术语英汉对照109例
1．便利店（Convenience Store，简称Cv.S）
2．超级市场（Super Market，简称SM）
3．大卖场、大型超市（Hyper Market）
4．联合店（Combination Store）
5．超级商店（Super Store）
6．专卖店（Exclusive Shop）
7．专业店（Specialty Store，简称HS或SS）
8．量贩店（Variety Store，简称VS）
9．百货商店（Department Store）
10．折扣店（Discount Store，简称DS）
11．仓储式会员店（Warehouse Club）
12．厂家店（Factory Outlets）
13．大型综合超市（General Merchandise Store，简称GMS）
14．单品店（Single-Line Store）
15．中心（Single-Line Store）
16．快餐店（Fast-food Outlets）
17．超级专卖店（Super Specialty）
18．仓储式销售（Warehouse Retailing）
19．计算机商店（Computer Store）
20．电子超级店（Electronics Super Store）
21．超大购物中心（Mega Mall）
22．电子购物（Electronic Shopping）
23．美国巨型市场（American Hyper Market）
24．连锁店（Chain Store）
25．QR（Quick Response）服装衣料业为减少缺货、缩短加工时间，减少经营费用，能准确。

本文格式为 Word 版，下载可任意编辑，页眉双击删除即可。
英文目录格式 [英文目录]
State-owned Housing Intermediaries It was reported that Beijing will set up state-owned housing
Future Development of Shanghai Economic growth rate of Shanghai dropped to only 7% in the first quarter of 2021, marking the lowest one among all the provincial districts. As a window to observe China’s development, Shanghai’s situation leads to some experts’ hard-landing consideration of the whole economy. How to improve innovation and complete transformation of development pattern is not only the task faced by Shanghai, but also a key factor to the prospect of Chinese economy.
intermediaries, which has caused consideration and controversy as the market is currently measuring the government intervention. Some experts consider that the policy will encounter difficulties in practice.

附录3 英文目录示例

58885-1-S-000-1610-0001_50_0010-1-Chinese-中英对照-第3版本-Final

英语目录与提要范文

附录.外文翻译 doc

2019-合同通用条款范本目录(英文)word版本 (5页)

英文产品目录

经典 中英对照 ICH CTD 目录 Module 1, 2, 3, 4, 5

英文附录部分

英语作文目录模板

附录3参考文献译文本示例(20150316).

产品目录英文版

附录3-英文目录示例

lwgf

英文商务合同chp3

英语作文目录模板

附录3.pdf[共4页]

英文目录格式 [英文目录]

经典中英对照 ICH CTD 目录 Module 1, 2, 3, 4, 5